A Universal Chemotactic Targeted Delivery Strategy for Inflammatory Diseases

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Materials Science

Background:

• Chronic inflammatory diseases cause over 50% of deaths globally.
• Targeted drug delivery systems are crucial for managing inflammation.
• Current strategies often lack precision in reaching inflammatory sites.

Purpose of the Study:

• To propose a zwitterion-based artificial chemotactic nanomotor for precise in vivo targeting.
• To utilize elevated reactive oxygen species (ROS) and inducible nitric oxide synthase (iNOS) as chemoattractants.
• To evaluate the nanomotor's chemotactic performance in inflammation models.

Main Methods:

• Development of zwitterion-based artificial chemotactic nanomotors.
• Establishment of multidimensional static, dynamic, and in vivo models.
• Mesoscale hydrodynamics simulations to analyze nanomotor behavior.
• Evaluation of nanomotor chemotaxis in inflammation-related disease models.

Main Results:

• Upregulated ROS and iNOS levels successfully induced nanomotor chemotaxis towards diseased tissues.
• Demonstrated precise targeting capabilities in vivo.
• Mesoscale simulations elucidated the underlying chemotactic mechanisms.

Conclusions:

• The proposed chemotactic nanomotor strategy offers a universal and precise targeting approach.
• This method shows potential for improved drug delivery efficiency in inflammatory diseases.
• The strategy is adaptable for various inflammatory conditions.